SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Regentis Biomaterials Ltd. (RGNT) News

Track canonical SquawkNews coverage tagged to RGNT, Regentis Biomaterials Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol RGNT Asset equity Sector Markets 90 days 2 Last 2.01 Updated Jul 15, 2026, 01:02 PM UTC Open live news feed
L Regentis Biomaterials Receives European Regulatory Approval For New GelrinC Manufacturing Process The approval comes as Regentis prepares for the commercial launch of GelrinC® in Europe, enabling the Company to manufacture commercial product using a process that increases production yield by approximately 400%, deliv RATES | Jul 15, 2026, 01:02 PM UTC L 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Can Fite Biopharma (AMEX: CANF ) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ: RGC ) stock moved upwards by 35.79% t EQUITY | Jul 01, 2026, 05:05 PM UTC